Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 278 No 7442 p270
10 March 2007

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Framework lays plans for flexible commissioning

Has1sue/Dreamstime.com

Double-glazing

GPs could find themselves ordering double-glazing

A framework to help commissioners deliver NHS services effectively and to improve both the health and well-being of individuals has been published by the Department of Health.

It includes proposals that would see the NHS paying for services more traditionally aligned with social care — for example, it suggests that GPs might arrange for double-glazing to be fitted in the homes of people with breathing difficulties. It also proposes a new duty for councils, primary care trusts and practice-based commissioners to prepare joint strategic needs assessments.

The document suggests that more needs to be done to provide incentives for innovation and to join up services, adding that there are too few providers. It also recommends that commissioners should develop strong partnerships with providers and engage them in needs assessments.

“Procurement should be transparent and fair. Commissioning will be focused on outcomes, leading to more innovative provision, tailored to the needs of individuals and supplied by a wider range of providers,” it states.

The framework was launched by health secretary Patricia Hewitt at a conference in London this week, who also announced an extra £8.9m funding for local authorities across England to invest in schemes to tackle health inequalities.

She said: “We need to radically change the culture of how we shape and deliver care — shifting focus from curing the sick to the proactive prevention of ill health, as well as tackling health inequalities. I want to see greater flexibility in the use of resources to target investment where it will have biggest impact to improve health and prevent premature death.”

The “Commissioning framework for health and wellbeing” is open for comment until 28 May 2007.

Back to Top


©The Pharmaceutical Journal